Mourad Barhoumi - Epidemiology

Author Information

Mourad Barhoumi is affiliated with the Laboratory of Molecular Epidemiology and Experimental Pathology at the Institut Pasteur de Tunis, Université Tunis El Manar, located in Tunis, Tunisia. His research is primarily focused on the study of infectious diseases, particularly those caused by protozoan parasites like Leishmania. His work combines molecular epidemiology and experimental pathology to gain insights into the mechanisms of infection and potential therapeutic interventions.

Research Contributions

Mourad Barhoumi has made significant contributions to the understanding of Leishmania, a protozoan parasite responsible for leishmaniasis. His research has involved in silico identification of potential RNA helicases from Leishmania infantum, as well as analyses of population structure and genetic diversity in Leishmania tropica. He has also explored the adjuvant properties of Leishmania proteins and their roles in the immune response, particularly in the context of vaccine development. His studies often employ advanced methodologies such as Bayesian phylogenetic analysis and virtual screening to discover novel therapeutic targets.

Aliases

Mourad Barhoumi is also known by several aliases, including M Barhoumi and M. Barhoumi. These variations may appear in different publications or citations.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	28
Total Citation Count	384
H-index	10

Publications:

The In Silico Identification of Potential Members of the Ded1/DDX3 Subfamily of DEAD-Box RNA Helicases from the Protozoan Parasite Leishmania infantum and Their Analyses in Yeast

DOI: 10.3390/genes12020212

Year: 2021

New Insights on the Adjuvant Properties of the Leishmania Infantum Eukaryotic Initiation Factor

DOI: 10.37247/paimmu2ed.2.2021.11

Year: 2021

Multilocus sequence analysis provides new insight into population structure and genetic diversity of Leishmania tropica in Morocco.

DOI: 10.1016/j.meegid.2021.104932

Year: 2021

Infection of Human Neutrophils With Leishmania infantum or Leishmania major Strains Triggers Activation and Differential Cytokines Release

DOI: 10.3389/fcimb.2019.00153

Year: 2019

New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor

DOI: 10.1155/2019/9124326

Year: 2019

Bayesian phylogenetic analysis of the influenza-A virus genomes isolated in Tunisia, and determination of potential recombination events.

DOI: 10.1016/j.ympev.2019.01.019

Year: 2019

Leishmania infantum LeIF and its recombinant polypeptides induce the maturation of dendritic cells in vitro: An insight for dendritic cells based vaccine.

DOI: 10.1016/j.imlet.2019.04.001

Year: 2019

Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic translation initiation factor 4A

DOI: 10.1371/journal.pntd.0006160

Year: 2018

The steroid derivative 6-aminocholestanol inhibits the DEAD-box helicase eIF4A (LieIF4A) from the Trypanosomatid parasite Leishmania by perturbing the RNA and ATP binding sites.

DOI: 10.1016/j.molbiopara.2018.10.001

Year: 2018

Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic initiation factor 4 A

DOI:

Year: 2018

What are the Benefits of Exercise Across Different Age Groups?

What are the Key Privacy Measures in Epidemiology?

How Do Age Ranges Interact with Other Variables?

Why Is Breast Cancer Screening Important?

How to Interpret the AUC-ROC Curve?

How Does Decaying Organic Matter Affect Human Health?

What is Behavioral Support in Epidemiology?

How Do Logistical Failures Affect Disease Control?

What are Educational Campaigns in Epidemiology?

Were Ethical Considerations Addressed?

Partnered Content Networks

Relevant Topics